Annelize Koch
3G'S Development Trust(GB)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Eating Disorders and Behaviors, Neuropeptides and Animal Physiology, Pharmaceutical studies and practices, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People(2012)93 cited
- → Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria(2021)87 cited
- → Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting(2017)69 cited
- → The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects(2011)60 cited
- → Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist(2011)49 cited
- → Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti‐CD38 cytolytic antibody TAK‐079 in healthy subjects(2020)40 cited
- → Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters(2012)39 cited
- → Effect of dopamine D3 receptor antagonism on approach responses to food cues in overweight and obese individuals(2012)36 cited
- → Use of Entero‐Test, a simple approach for non‐invasive clinical evaluation of the biliary disposition of drugs(2011)34 cited
- → GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes(2016)33 cited